WallStreetZenWallStreetZen

NASDAQ: ACET
Adicet Bio Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ACET

Based on 2 analysts offering 12 month price targets for Adicet Bio Inc

Min Forecast
$4.00+462.59%
Avg Forecast
$5.50+673.56%
Max Forecast
$7.00+884.53%

Should I buy or sell ACET stock?

Based on 2 analysts offering ratings for Adicet Bio Inc.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ACET's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates ACET as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their ACET stock forecasts and price targets.

ACET stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-07-23
lockedlocked$00.00+00.00%2025-03-21

1 of 1

Forecast return on equity

Is ACET forecast to generate an efficient return?

Company
-47.64%
Industry
123.58%
Market
-47.74%
ACET's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ACET forecast to generate an efficient return on assets?

Company
-40.22%
Industry
46.72%
ACET is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ACET earnings per share forecast

What is ACET's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$1.10
Avg 2 year Forecast
-$1.00
Avg 3 year Forecast
-$0.97

ACET revenue forecast

What is ACET's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$203.4M
Avg 2 year Forecast
$465.4M

ACET vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ACET$0.71$5.50+673.56%Strong Buy
ALXO$1.10$3.30+200.00%Strong Buy
IMMX$2.10$7.00+233.33%Buy
SLGL$21.00N/AN/A
INMB$2.24$4.30+91.96%Buy
View Top Biotech Stocks

Adicet Bio Stock Forecast FAQ

Is Adicet Bio Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: ACET) stock is to Strong Buy ACET stock.

Out of 2 analysts, 1 (50%) are recommending ACET as a Strong Buy, 1 (50%) are recommending ACET as a Buy, 0 (0%) are recommending ACET as a Hold, 0 (0%) are recommending ACET as a Sell, and 0 (0%) are recommending ACET as a Strong Sell.

If you're new to stock investing, here's how to buy Adicet Bio stock.

What is ACET's earnings growth forecast for 2025-2027?

(NASDAQ: ACET) Adicet Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.36%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.32%.

Adicet Bio's earnings in 2025 is -$117,320,000.On average, 4 Wall Street analysts forecast ACET's earnings for 2025 to be -$90,980,588, with the lowest ACET earnings forecast at -$103,387,031, and the highest ACET earnings forecast at -$78,574,144. On average, 4 Wall Street analysts forecast ACET's earnings for 2026 to be -$82,502,851, with the lowest ACET earnings forecast at -$97,597,358, and the highest ACET earnings forecast at -$71,957,374.

In 2027, ACET is forecast to generate -$79,814,788 in earnings, with the lowest earnings forecast at -$82,709,625 and the highest earnings forecast at -$76,919,951.

What is ACET's revenue growth forecast for 2030-2031?

(NASDAQ: ACET) Adicet Bio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 80.59%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.89%.

Adicet Bio's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast ACET's revenue for 2030 to be $16,826,446,110, with the lowest ACET revenue forecast at $16,826,446,110, and the highest ACET revenue forecast at $16,826,446,110.

In 2031, ACET is forecast to generate $38,492,232,379 in revenue, with the lowest revenue forecast at $38,492,232,379 and the highest revenue forecast at $38,492,232,379.

What is ACET's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: ACET) forecast ROA is -40.22%, which is lower than the forecast US Biotechnology industry average of 46.72%.

What is ACET's Price Target?

According to 2 Wall Street analysts that have issued a 1 year ACET price target, the average ACET price target is $5.50, with the highest ACET stock price forecast at $7.00 and the lowest ACET stock price forecast at $4.00.

On average, Wall Street analysts predict that Adicet Bio's share price could reach $5.50 by Jul 23, 2026. The average Adicet Bio stock price prediction forecasts a potential upside of 673.56% from the current ACET share price of $0.71.

What is ACET's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: ACET) Adicet Bio's current Earnings Per Share (EPS) is -$1.29. On average, analysts forecast that ACET's EPS will be -$1.10 for 2025, with the lowest EPS forecast at -$1.25, and the highest EPS forecast at -$0.95. On average, analysts forecast that ACET's EPS will be -$1.00 for 2026, with the lowest EPS forecast at -$1.18, and the highest EPS forecast at -$0.87. In 2027, ACET's EPS is forecast to hit -$0.97 (min: -$1.00, max: -$0.93).

What is ACET's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: ACET) forecast ROE is -47.64%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.